Biopharma360
Life Sciences
- Website
- biopharma360.com · all feeds from this site
- Feed URL
https://biopharma360.com/feed/
Read it in your FeedListing reader
Or add to: Feedly Inoreader Raw feed
Latest posts
-
The Future Of Medicine: How AI Is Revolutionizing Pharma
The artificial intelligence (AI) revolution seems to pick up pace from one week to the next, but what does it mean for the pharmaceutical sector? Since its inception, the pharmaceutical industry has been at the forefront of human knowledge and innovation, occasionally driving…
-
FDA panel makes the call on much-anticipated Alzheimer’s drug donanemab
A Food and Drug Administration advisory panel on Monday endorsed the experimental Alzheimer’s drug donanemab, which studies showed slowed early stages of the fatal mind-robbing disease. The recommendation came despite pointed questions from advisory committee members about the…
-
InnovationRx: Tarsus Pharmaceuticals Takes Aim At Disease-Causing Bugs
Around 25 million Americans are affected by the eye disease Demodex blepharitis, which is caused by small mites that make their way into the eyelid. This causes chronic inflammation that can, in severe cases, cause problems on the cornea of the eye itself. The disease can also…
-
Amylyx Pharma to remove ALS drug from US, Canada markets
April 4 (Reuters) – Amylyx Pharmaceuticals (AMLX.O), opens new tab will withdraw its amyotrophic lateral sclerosis (ALS) drug – its only product in the market – from the U.S. and Canada after the treatment failed in a key late-stage trial. The drugmaker on Thursday also…
-
AI Helps Pharma Find New Drugs But Imperils Lucrative Patents
Artificial intelligence has emerged as a double-edged sword for pharmaceutical companies, helping to develop new cures while also creating obstacles to obtaining drug patents potentially worth billions. A vast trove of AI creations would make it increasingly difficult for…
-
ProMed Pharma Acquires SpineThera Manufacturing Capabilities
PLYMOUTH, Minn.–(BUSINESS WIRE)–SpineThera, Inc., a privately held, clinical-stage pharmaceutical company focused on the development of SX600 (a novel formulation of extended-release dexamethasone microspheres for epidural injection for the management of lumbar radicular pain)…